• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs).通过虚拟筛选确定细菌烟酰胺腺嘌呤二核苷酸合成酶(NADs)的先导抑制剂。
Bioorg Med Chem Lett. 2009 Apr 1;19(7):2001-5. doi: 10.1016/j.bmcl.2009.02.034. Epub 2009 Feb 12.
2
SAR studies for a new class of antibacterial NAD biosynthesis inhibitors.新型抗菌NAD生物合成抑制剂的构效关系研究
J Comb Chem. 2009 Jul-Aug;11(4):617-25. doi: 10.1021/cc9000357.
3
Tethered dimers as NAD synthetase inhibitors with antibacterial activity.
J Med Chem. 2003 Jul 17;46(15):3371-81. doi: 10.1021/jm030003x.
4
[Microbial NAD synthetase and its inhibitors--a review].[微生物NAD合成酶及其抑制剂——综述]
Wei Sheng Wu Xue Bao. 2011 Mar;51(3):305-12.
5
Antibacterial nicotinamide adenine dinucleotide synthetase inhibitors: amide- and ether-linked tethered dimers with alpha-amino acid end groups.抗菌烟酰胺腺嘌呤二核苷酸合成酶抑制剂:具有α-氨基酸端基的酰胺和醚连接的 tethered 二聚体 。 (注:“tethered”这里可能是个特定专业术语,不太明确其准确含义,暂直译为“tethered” )
J Med Chem. 2007 May 31;50(11):2612-21. doi: 10.1021/jm061349l. Epub 2007 May 10.
6
Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD) synthetase inhibitors as potential antitubercular agents.作为潜在抗结核药物的取代烟酰胺腺嘌呤二核苷酸(NAD)合成酶抑制剂的设计、合成及评估
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4426-4430. doi: 10.1016/j.bmcl.2017.08.012. Epub 2017 Aug 8.
7
Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.设计、合成及生物评价抗布氏锥虫硫醇合成酶抑制剂。
ChemMedChem. 2012 Jan 2;7(1):95-106. doi: 10.1002/cmdc.201100420. Epub 2011 Dec 8.
8
Glutamine versus ammonia utilization in the NAD synthetase family.谷氨酰胺与氨在 NAD 合成酶家族中的利用。
PLoS One. 2012;7(6):e39115. doi: 10.1371/journal.pone.0039115. Epub 2012 Jun 15.
9
Tethered dimer inhibitors of NAD synthetase: parallel synthesis of an aryl-substituted SAR library.
J Comb Chem. 2005 Nov-Dec;7(6):898-904. doi: 10.1021/cc050063j.
10
Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.通过基于结构的虚拟筛选发现细菌肽聚糖生物合成酶MurD和MurF的新型抑制剂。
Bioorg Med Chem. 2009 Mar 1;17(5):1884-9. doi: 10.1016/j.bmc.2009.01.052. Epub 2009 Jan 29.

引用本文的文献

1
In silico studies on nicotinamide analogs as competitive inhibitors of nicotinamidase in methicillin-resistant Staphylococcus aureus.关于烟酰胺类似物作为耐甲氧西林金黄色葡萄球菌中烟酰胺酶竞争性抑制剂的计算机模拟研究
Mol Divers. 2024 Nov 13. doi: 10.1007/s11030-024-11036-y.
2
Inhibitors of NAD Production in Cancer Treatment: State of the Art and Perspectives.在癌症治疗中抑制 NAD 产生:现状与展望。
Int J Mol Sci. 2024 Feb 8;25(4):2092. doi: 10.3390/ijms25042092.
3
Docking of T6361 Analogues as Potential Inhibitors of MurA Followed by ADME-Toxicity Study.T6361 类似物作为 MurA 潜在抑制剂的对接研究及其随后的 ADME-毒性研究。
Curr Drug Discov Technol. 2024;21(3):1-8. doi: 10.2174/0115701638244582231025110143.
4
Advances in NAD-Lowering Agents for Cancer Treatment.降低 NAD 水平的癌症治疗药物的研究进展。
Nutrients. 2021 May 14;13(5):1665. doi: 10.3390/nu13051665.
5
Novel Antimycobacterial Compounds Suppress NAD Biogenesis by Targeting a Unique Pocket of NaMN Adenylyltransferase.新型抗分枝杆菌化合物通过靶向 NaMN 腺嘌呤核苷转移酶的独特口袋抑制 NAD 生物发生。
ACS Chem Biol. 2019 May 17;14(5):949-958. doi: 10.1021/acschembio.9b00124. Epub 2019 Apr 17.
6
Ligand binding to a remote site thermodynamically corrects the F508del mutation in the human cystic fibrosis transmembrane conductance regulator.配体与远程位点的结合在热力学上纠正了人类囊性纤维化跨膜电导调节因子中的 F508del 突变。
J Biol Chem. 2018 Nov 16;293(46):17685-17704. doi: 10.1074/jbc.RA117.000819. Epub 2018 Jun 14.
7
Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD) synthetase inhibitors as potential antitubercular agents.作为潜在抗结核药物的取代烟酰胺腺嘌呤二核苷酸(NAD)合成酶抑制剂的设计、合成及评估
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4426-4430. doi: 10.1016/j.bmcl.2017.08.012. Epub 2017 Aug 8.
8
Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteria.分枝杆菌中NadD和NadE酶靶向抑制的代谢和杀菌作用。
mBio. 2014 Feb 18;5(1):e00747-13. doi: 10.1128/mBio.00747-13.
9
Rapid countermeasure discovery against Francisella tularensis based on a metabolic network reconstruction.基于代谢网络重建的兔热病弗朗西斯菌快速对策发现。
PLoS One. 2013 May 21;8(5):e63369. doi: 10.1371/journal.pone.0063369. Print 2013.
10
Quinolinate salvage and insights for targeting NAD biosynthesis in group A streptococci.喹诺林盐的补救途径以及靶向 A 组链球菌 NAD 生物合成的研究进展。
J Bacteriol. 2013 Feb;195(4):726-32. doi: 10.1128/JB.02002-12. Epub 2012 Nov 30.

本文引用的文献

1
Signalling inhibitors against Mycobacterium tuberculosis--early days of a new therapeutic concept in tuberculosis.针对结核分枝杆菌的信号传导抑制剂——结核病新治疗理念的早期阶段
Curr Med Chem. 2008;15(26):2760-70. doi: 10.2174/092986708786242886.
2
Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors.非肽类胃蛋白酶II和IV抑制剂的计算机辅助设计与合成
ChemMedChem. 2008 Sep;3(9):1323-36. doi: 10.1002/cmdc.200700270.
3
From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.从虚拟到现实——基于药物化学视角的先导化合物发现与优化中的虚拟筛选
Curr Opin Drug Discov Devel. 2008 Jul;11(4):559-68.
4
Virtual screening and its integration with modern drug design technologies.虚拟筛选及其与现代药物设计技术的整合。
Curr Med Chem. 2008;15(1):37-46. doi: 10.2174/092986708783330683.
5
Cell-mediated defense against Yersinia pestis infection.针对鼠疫耶尔森菌感染的细胞介导防御。
Adv Exp Med Biol. 2007;603:376-86. doi: 10.1007/978-0-387-72124-8_35.
6
Structural adaptation of an interacting non-native C-terminal helical extension revealed in the crystal structure of NAD+ synthetase from Bacillus anthracis.炭疽芽孢杆菌NAD⁺合成酶晶体结构中揭示的相互作用的非天然C末端螺旋延伸的结构适应性
Acta Crystallogr D Biol Crystallogr. 2007 Aug;63(Pt 8):891-905. doi: 10.1107/S0907444907029769. Epub 2007 Jul 17.
7
Antibacterial nicotinamide adenine dinucleotide synthetase inhibitors: amide- and ether-linked tethered dimers with alpha-amino acid end groups.抗菌烟酰胺腺嘌呤二核苷酸合成酶抑制剂:具有α-氨基酸端基的酰胺和醚连接的 tethered 二聚体 。 (注:“tethered”这里可能是个特定专业术语,不太明确其准确含义,暂直译为“tethered” )
J Med Chem. 2007 May 31;50(11):2612-21. doi: 10.1021/jm061349l. Epub 2007 May 10.
8
Identification of potential glycogen kinase-3 inhibitors by structure based virtual screening.基于结构的虚拟筛选鉴定潜在的糖原激酶-3抑制剂
Biophys Chem. 2007 Jul;128(2-3):165-75. doi: 10.1016/j.bpc.2007.04.001. Epub 2007 Apr 19.
9
Francisella tularensis travels a novel, twisted road within macrophages.土拉弗朗西斯菌在巨噬细胞内走出了一条独特而曲折的路径。
Trends Microbiol. 2006 Jan;14(1):37-44. doi: 10.1016/j.tim.2005.11.008. Epub 2005 Dec 13.
10
Tethered dimer inhibitors of NAD synthetase: parallel synthesis of an aryl-substituted SAR library.
J Comb Chem. 2005 Nov-Dec;7(6):898-904. doi: 10.1021/cc050063j.

通过虚拟筛选确定细菌烟酰胺腺嘌呤二核苷酸合成酶(NADs)的先导抑制剂。

Virtual screening to identify lead inhibitors for bacterial NAD synthetase (NADs).

作者信息

Moro Whitney Beysselance, Yang Zhengrong, Kane Tasha A, Brouillette Christie G, Brouillette Wayne J

机构信息

Center for Biophysical Sciences and Engineering, University of Alabama at Birmingham, 1025 18th Street South, Birmingham, AL 35294, United States.

出版信息

Bioorg Med Chem Lett. 2009 Apr 1;19(7):2001-5. doi: 10.1016/j.bmcl.2009.02.034. Epub 2009 Feb 12.

DOI:10.1016/j.bmcl.2009.02.034
PMID:19249205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2666046/
Abstract

Virtual screening was employed to identify new drug-like inhibitors of NAD synthetase (NADs) as antibacterial agents. Four databases of commercially available compounds were docked against three subsites of the NADs active site using FlexX in conjunction with CScore. Over 200 commercial compounds were purchased and evaluated in enzyme inhibition and antibacterial assays. 18 compounds inhibited NADs at or below 100 microM (7.6% hit rate), and two were selected for future SAR studies.

摘要

采用虚拟筛选来鉴定新型类药物的烟酰胺腺嘌呤二核苷酸合成酶(NADs)抑制剂作为抗菌剂。使用FlexX结合CScore,将四个市售化合物数据库与NADs活性位点的三个亚位点进行对接。购买了200多种商业化合物,并在酶抑制和抗菌试验中进行评估。18种化合物在100微摩尔或更低浓度下抑制NADs(命中率为7.6%),并选择了两种用于未来的构效关系研究。